Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Global WholeHealth Partners Corp. (GWHP-OTC) Acquires Rights to Distribute & Sell Johnson & Johnson COVID-19 Vaccine

Read more ››
By: GlobenewsWire - 14 Jun 2021

MediciNova to Participate in Maxim Group LLC Fireside Chat

Read more ››
By: GlobenewsWire - 14 Jun 2021

EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study

Read more ››
By: GlobenewsWire - 14 Jun 2021

Aleafia Health Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-on

Read more ››
By: GlobenewsWire - 14 Jun 2021

Allarity Therapeutics and Oncoheroes Biosciences to Partner on Pediatric Cancer Development of Dovitinib and Stenoparib

Read more ››
By: GlobenewsWire - 14 Jun 2021

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

Read more ››
By: GlobenewsWire - 14 Jun 2021

GBT’s Voxelotor is First Sickle Cell Disease Treatment to Receive Promising Innovative Medicine (PIM) Designation in the UK

Read more ››
By: GlobenewsWire - 14 Jun 2021

Opthea Appoints Company Secretary and Vice President of Finance

Read more ››
By: GlobenewsWire - 14 Jun 2021

G1 Therapeutics Initiates PRESERVE 3, A Randomized Phase 2 Study of COSELA™ (trilaciclib) in Bladder Cancer

Read more ››
By: GlobenewsWire - 14 Jun 2021

Athira Pharma Appoints Rachel Lenington as Chief Technology Officer, Head of Product Development Strategy

Read more ››
By: GlobenewsWire - 14 Jun 2021

iTeos Therapeutics and GSK announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal antibody, enabling novel next-generation immuno-oncology combinations

Read more ››
By: GlobenewsWire - 14 Jun 2021

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

Read more ››
By: GlobenewsWire - 14 Jun 2021

Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor in Mild-to-Moderate Active Ulcerative Colitis (UC) Patients

Read more ››
By: GlobenewsWire - 14 Jun 2021

Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol

Read more ››
By: GlobenewsWire - 14 Jun 2021

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

Read more ››
By: GlobenewsWire - 14 Jun 2021

Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors

Read more ››
By: GlobenewsWire - 14 Jun 2021

Anavex Life Sciences Reports New Publication in Medical Journal Elucidating the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B) related to the Treatment of Alzheimer's Disease

Read more ››
By: GlobenewsWire - 14 Jun 2021

ALX Oncology Announces Update on ASPEN-03 and ASPEN-04, the ALX148 Phase 2 Head and Neck Cancer Studies

Read more ››
By: GlobenewsWire - 14 Jun 2021

Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term

Read more ››
By: GlobenewsWire - 14 Jun 2021

Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH

Read more ››
By: GlobenewsWire - 14 Jun 2021
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate